Ncardia will attend and present at this year's ELRIG meeting in Darmstadt, Germany
Meet Ralf Kettenhofen, Ncardia's Head of Product Management, at ELRIG 2018 to learn more about the latest developments with our hiPSC-derived cell portfolio, services and applications.
Ralf has been invited to give the following talk:
- "Human induced pluripotent stem cell-derived cardiomyocytes - case studies for the application in early drug development"
Don't miss this opportunity to chat with Ralf and learn more about Ncardia! Would you like to get in touch with Ralf prior to ELRIG? Send him an email now!